Thu, February 21, 2013
Wed, February 20, 2013
[ Wed, Feb 20th 2013 ]: Market Wire
Goldstrike Closes Financing
Tue, February 19, 2013
Mon, February 18, 2013
[ Mon, Feb 18th 2013 ]: Market Wire
Issue of Equity Amendment
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $64 on, Feb 19th, 2013


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-64-on-feb-19th-2013.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $55 to $64 on, Feb 19th, 2013.

Christopher has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013
  • Martin Auster of "UBS" Maintained at Strong Buy with Increased Target to $67 on, Friday, February 1st, 2013
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $54 on, Tuesday, November 6th, 2012

Publication Contributing Sources